Trial Profile
Study of the change of dietary intake and contents after taking selective SGLT2 inhibitor, Ipragliflozin
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Dec 2014
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 20 Dec 2014 New trial record